REGENEREX PHARMA, INC. Deferred Tax Assets, Net of Valuation Allowance, Noncurrent
REGENEREX PHARMA, INC. had Deferred Tax Assets, Net of Valuation Allowance, Noncurrent of -$160.00 thousand as of 2018-03-31, per its 10-K filed 2019-06-24.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetNoncurrent · last filed 2019-06-24
- 2018-03-31: Deferred Tax Assets, Net of Valuation Allowance, Noncurrent -$160.00K; Deferred Tax Assets, Net of Valuation Allowance, Noncurrent as first filed $154.00K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Noncurrent | Deferred Tax Assets, Net of Valuation Allowance, Noncurrent as first filed |
|---|---|---|
| 2018-03-31 | -$160.00K 10-K · filed 2019-06-24 | $154.00K 10-K · filed 2018-06-21 |